Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Accurately Assessing the Extent of Titanium Leaks from Implants

By LabMedica International staff writers
Posted on 03 Aug 2011
A highly sensitive method to determine the levels of titanium (Ti) in human blood will help quantify Ti concentrations in patients fitted with orthopedic implants. More...


Researchers at the University of Oviedo (Spain) collected blood samples from 40 healthy individuals and 37 patients with Ti implants - 15 with tibia implants, eight with femur implants, and 14 with humerus implants (eight internal and six external fixation implants). Using isotope dilution analysis and mass spectrometry (IDA-ICP-MS), the researchers then analyzed the blood samples with a double-focusing inductively coupled plasma mass spectrometer.

The results showed that control individuals had very low levels of Ti in the blood (mean 0.26 g/L), whereas Ti concentrations were significantly higher for all the patients with implants. The sensitivity of the method was such that the researchers were also able to show significant differences in Ti levels for different types of bone fixation devices; the more invasive implants shed more metallic debris into the blood than the external, superficial designs. The study also identified how the Ti from the implants is transported in the bloodstream and potentially distributed and accumulated. The study was published early online on July 22, 2011, in Analytical and Bioanalytical Chemistry.

“The simplicity of the methodology based on isotope dilution analysis and the accuracy and precision of the obtained results should encourage the use of the proposed strategy on a routine basis,” concluded lead author PhD student Yoana Nuevo-Ordonez, MSc, and colleagues of the department of physical and analytical chemistry.

Titanium implants are routinely used for treating bone fractures, as well as in dental work. Recent studies have shown that Ti-based implants both corrode and degrade, generating metallic debris with potentially harmful biological effects over time, including hepatic injury and renal lesions. To assess possible implications it is first essential to accurately measure the basal, normal levels of Ti in the bloodstream, as well as quantify how much higher the levels are in patients with implants.

Related Links:

University of Oviedo



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.